Suggestion of suitable animal models for in vivo studies of protein tyrosine phosphatase 1b (PTP1B) inhibitors using computational approaches by Xuan Thi-Anh Nguyen & Ly Le
a SpringerOpen Journal
Nguyen and Le SpringerPlus 2014, 3:380
http://www.springerplus.com/content/3/1/380RESEARCH Open AccessSuggestion of suitable animal models for in vivo
studies of protein tyrosine phosphatase 1b
(PTP1B) inhibitors using computational
approaches
Xuan Thi-Anh Nguyen1 and Ly Le1,2*Abstract
PTP1B is a prototypic enzyme of the superfamily protein tyrosine phosphatases (PTPs) which are critical regulators
of tyrosine phosphorylation-dependent signaling events. It is a highly plausible candidate for designing therapeutic
inhibitors of obesity and type 2 diabetes (T2D). In this study, a detailed comparative analysis to reveal the evolutionary
relationship of human PTP1B among related vertebrates has been addressed.
The phylogenetic trees were constructed with maximum likelihood algorithm by PhyML package on the basis of
multiple sequence alignment (MSA) by ClustalΩ and T-coffee. Mutational variability of the sequences corresponding to
the 3D structure (pdb: 2vev) was analyzed with Consurf software. The comparative analysis by inhibitor docking to
different models was made to confirm the suitability of models.
As a result, the PTP1B or PTP non-receptor type 1 homologies show high conservativity where about 70%
positions on primary structures are conserved. Within PTP domain (3–277), the most variable positions are 12, 13,
19 and 24 which is a part of the second aryl binding site. Moreover, there are important evolutional mutations that
can change the conformation of the proteins, for instance, hydrophilic N139 changed to hydrophobic Gly
(mPTP1B); E132 to proline in the hydrophobic core structure or Y46 to cystein in pTyr recognition loop. These
variations/differences should be taken into account for rational inhibitor design and in choosing suitable animal
models for drug testing and evaluation. Moreover, our study suggests critically potential models which are
Heterocephalus glaber, Tupaia chinensis, Sus scrofa, and Rattus norvegicus in addition to the best one Macaca
fascicularis. Among these models, the H.glaber and R.norvegicus are preferable over M.musculus thanks to their
similarity in binding affinity and binding modes to investigated PTP1B inhibitors.
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Among the PTPs superfamily, PTP1B has become prom-
inent for its down regulation of both insulin and leptin
signaling and control of glucose homeostasis and energy
expenditure (Tsou and Bence 2012). It terminates the sig-
naling cascade by dephosphorylating the tyrosine residues
on its substrates, the phosphotyrosine kinases (PTKs). As* Correspondence: ly.le@hcmiu.edu.vn
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signaling, moreover, PTP1B is recognized to be a key link
between metabolic diseases (Tonks 2003), inflammation
(Pike et al. 2014) and cancer (Feldhammer et al. 2013).
In insulin signaling, PTP1B acts to dephosphorylate the
insulin receptor (IR) at tandem Y1162/Y1163 (Tsou and
Bence 2012; Galic et al. 2005) and possibly the insulin re-
ceptor substrate 1 (IRS-1) (Galic et al. 2005). Increasing
expressed PTP1B and its activity result in over dephos-
phorylation of IR and kinases leading to interruption of
insulin cascades and hence insulin resistance in target
tissues.is an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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signaling via direct dephosphorylation of the active site
of the leptin receptor-associated tyrosine kinase JAK2
(Tsou and Bence 2012; Zabolotny et al. 2002; Cheng
et al. 2002; Myers et al. 2001). In common obesity, there’s
a phenomenon called leptin resistance reflecting the
failure of leptin to inhibit energy intake and to increase
energy expenditure (Enriori et al. 2006). Since its impact
on terminating the leptin signaling, PTP1B is a highly
plausible candidate for therapeutic inhibitors to restore
leptin sensitivity and prevent disease in the non-adipose
tissues (Cook and Unger 2002).
Interestingly, PTP1B-deficient mice were shown to in-
crease insulin sensitivity and resistance to diet-induced
obesity (Kahn and Flier 2000; Elchebly et al. 1999;
Klaman et al. 2000). Since the discovery of PTP1B in
1988, it has become an important target for treat-
ment of diabetes mellitus and obesity. As over 80%
of individuals with T2D are obese (Nadler et al.
2000), PTP1B inhibition may be a potential strategy
for a therapeutic target of type 2 diabetes through
its links with obesity.
This protein has been well-studied in structure and
substrate binding (Tonks 2003). There are four import-
ant loops in the catalytic site which are PTP, pTyr, WPD
and Q loops. PTP loops contain the signature motif [I/V]
HCXXGXXR [S/T] which is highly conserved among clas-
sical PTP sub-family. The pTyr loop plays a role in recog-
nition of Tyr tandem in the substrate and contains Tyr46
which defines the depth of the binding site and con-
tributes to absolute substrate specificity of PTP1B to
phosphotyrosine-containing substrates. The Cys215 in
PTP loop, Asp181 in WPD loop and Gln262 in Q loop
are reactive residues essential for catalysis. The second
aryl binding site was characterized by Arg24, Arg254
and Gly259 (Andersen et al. 2001). This finding has
been supporting variety of PTP1B inhibitor studies
(Zhang and Lee 2003).
However, none of potential inhibitors could pass clin-
ical trials which lead to the need of thorough investigat-
ing on both functional and evolutionary relationships of
PTP1B to other PTPs and among species to avoid in-
hibitor side effects and to increase suitability of animal
in vivo test prior to clinical trials. Although the intra-
relation among PTP domains of human and vertebrates
was reviewed with sequence and partially structure ana-
lysis (Andersen et al. 2001), a detailed comparative
study to reveal the inter-relation specifically of human
PTP1B among related species has not been addressed
yet. Hence, the final objective of this study is to propose
potentially suitable animal models for in vivo drug test-
ing and strategies for further rational inhibitor designs
against PTP1B, particularly as treatment for obesity-
associated diabetes.Results and discussion
Phylogenetic study of PTP1B protein
The human PTP1B sequence (Uniprot: P18031) was used
as template for a protein Blast search of 250 sequences
maximum. Selecting from more than 200 sequences, only
27 homologous sequences of PTP1B among different ver-
tebrates qualified for further multiple sequence alignment
(MSA) by two algorithms ClustalΩ (Sievers et al. 2011)
and T-coffee (Notredame et al. 2000). Comparing the
results of the two alignments, there were three more
unmatched sequences (GenBank: EFN83906, GenBank:
EGW05519, RefSeq: XP_001654306) put aside from the
list. The final alignment of 24 homologous sequences
was further verified by the algorithm of genetic semiho-
mology (Leluk et al. 2001). The resulting MSA showed
relative similarity among sequences. Particularly, the
tyrosine-protein phosphatase (PTP) domains (3–277)
are well conserved. The PTP signature motif [I/V]
HCSAG [I/V] GRS and the WPD-loop motif which are
essential for catalysis and substrate trapping, respectively,
are completely conserved among the species (Figure 1).
The refined MSA was used as input for the phylogenetic
tree construction by the maximum likelihood algorithm.
The resulted phylogram shows two distinct branches
(Figure 2). The small group 1 with six distant species
including Schistosoma mansoni, Clonorchis sinensis,
Crassostrea gigas, Pediculus humanus corporis and Culex
quinquefasciatus. The larger group 2 with 17 species
starts from Danio to Homo sapiens. Group 2 can also
be divided into 3 subgroups (aside from Danio) which
are Xenopus group (subgroup 1); Chelonia and poultry
species (subgroup 2); and the biggest subgroup 3 ran-
ging from rodent species to human.
Protein sequences from monkey species Macaca fasci-
cularis, Macaca mulatta have the closest vicinity to
hPTP1B. However, they might not be preferable as animal
models because of bioethics for drug test in some cases.
The next important candidate is the Chinese treeshew
Tupaia chinensis. Although the sequence cover is not
closely guaranteed as Tupaia’s sequence is longer (598aa)
than that of human and therefore could lead to disagree-
ment in protein structure, the amino acid identity is high
in critical positions (refer to Figures 1 and 3).
Essentially, hPTP1B (P18031), in this study, acts as
indicator for choosing suitable animal models for
in vivo tests due to its relevance to clinical studies for
drug targeting (Sobhia et al. 2012). For this reason,
group 1 was not chosen for further analysis because of
distant evolution from hPTP1B. Furthermore, ptp1b
sequences from these species reveal critical variations/
mutations in PTP domains (Figure 3). Arg45 and
Tyr46 in pTyr recognition loop are mutated to Lys and
Cys respectively in Clonorchis. Within the Q loop
(262–269), there are variations observed in Pediculus
Figure 1 Multiple sequence alignment (part) of 24 vertebrate PTP1B amino acid sequences. The consensus sequence obtained with the
parameters: identity 91.67%, significance 29.17%, gaps 50%. Residues numbered according to hPTP1B.
Figure 2 Unrooted phylogentic tree of 24 species’ PTP1B homologous sequences. Phylograms obtained by PhyML 3.0.
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Figure 3 Variations in important binding sites of some sequences – (a) R24 second aryl binding site and pTyr recognition site;
(b) R254 & G259 second aryl binding site and Q-loop motif. Conserved residues in these positions are shown in red. The yellow square
indicates 6 species that have vigorous variations in these regions.
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W; R-K). Among those, the mutations from Asp265
(negatively charged) to Gly (hydrophobic) in Pediculus
may affect the conformation of the loop. Looking into
the second aryl binding site of the protein (Andersen
et al. 2001), Arg24 is quite varied in group 1 sequences.
Point mutations from R (positively charged) to E (negatively
charged), to L (hydrophobic) or even deleted (gapped)
may cause significant differences in substrate trapping/
interaction of the PTP1B in these species from that of
hPTP1B.
Analysis on evolutionary conservation
The PTP1B homologous sequences of group 2 among
18 selected species including human were analyzed
thoroughly by Consurf server. This test not only helped
resolve which are the most variable/conserved regions
on the protein but also contributed to the selection of
proper animal models.
Overall, the PTP1B protein is highly conserved at the
core structure of the catalytic domain (pdb: 2vev). There
are 219 positions absolutely conserved through evolu-
tion. Forty-eight positions are indicated with 2 different
residues while 27 positions with 3 various residues. A
variety of 4 residues occurs in 14 positions and 6 posi-
tions reveal high variations of 5 or 6 residues. The most
varied positions are 12, 13 and 19 which in hPTP1B are
lysine, serine and isoleucine (Figure 4).
Particularly, the variable residues/regions adjacent to
the conserved motifs range from 1 to 5 levels according
to Consurf color-coded MSA (Figure 5). Within the
motif KCAQYWP, the hydrophobic core structure, thatinteracts with ligand induced residues (Andersen et al.
2001), for instance, E132 in hPTP1B with a negatively
charge is exceedingly different from Pro in Xenopus laevis.
Another example is hydrophilic N139 variated signifi-
cantly into hydrophobic Gly in mPTP1B of Mus musculus
cautioning that this rodent might not be a good model for
PTP1B inhibitor-related studies. These mutations can
cause differences in conformation between the proteins of
human and the various species.
Based on the percentage of variations among sequences
to hPTP1B (data not shown) and the level of mutations as
well as the phylogenetic information, a table ranking po-
tential animal models was formed for later references
(Table 1). Noticeably, species of the subgroup 3 in branch
2 of the phylogenetic tree were among top of the rank and
hence considered as subjects for further analysis. Because
of bioethic issues related to primate species and economic
issues of Bos genus, however, there are only 7 models
suggested for next comparative analysis with inhibitor
dockings.Inhibitor docking into models’ PTP1B 3D structures
Seven candidates, Sus scrofa, Tupaia chinensis, Hetero-
cephalus glaber, Myotis brantdii, Pteropus alecto, Rattus
norvegicus and Mus musculus, which are available and
have high potential were chosen for further analysis on
structures and ligand interactions. The PTP1B proteins
of these animals have no experimental structures yet;
hence they are modeled as homologs from the template
2VEV of human PTP1B catalytic domain with 299 resi-
dues. The sequence identity of models to human template
Figure 4 Mutational variability of 18 aligned PTPN1 sequences in corresponding to PTP1B structure [PDB: 2VEV]. Labeled residues
indicate the most variable region(s). The figure was prepared by Chimera 1.8 with Consurf color codes.
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PTP1B catalytic domain is conserved (Additional file 1).
These models, along with hPTP1B (pdb: 2vev), were
investigated as to their ligand interaction by inhibitor
docking with Ertiprotafib (Ki 1500 nM) and five other
small molecules published as potential PTP1B antagonists
denoted as compounds 1 to 5 (Zhang and Lee 2003).
Compound 1 (affinity 220 nM) is peptidomimetics of 3-
carboxy-4-(O-carboxymethyl) tyrosine core that could
augment insulin action in the cell (Larsen et al. 2003).Figure 5 Consurf color-coded multiple sequence alignment (part) witCompound 2 (Ki 2 μM) is the ortho tetrazole analogue
in which tetrazole moiety is well-accommodated in
the active site (Liljebris et al. 2002). Compound 3
(Ki 0.6 μM) was developed by Novo Nordisk group
to address the second aryl phosphate-binding pocket
of PTP1B (Iversen et al. 2001). Abbott group investi-
gated about compound 4 (Ki 77 nM) for interacting
with both binding sites on the PTP1B enzyme (Liu
and Trevillyan 2002). The non-hydrolyzable analog,
compound 5 (Ki 2.4 nM), was the most potent inhibitorh conservativity score of 18 PTP1B homologous sequences.
Table 1 Ranking the candidates based on variation/conservativity level within PTP domains (275 residues)
Ranking Species Accession number
1 1.1.Macaca fascicularis (long-tailed macaque) 1. EHH65248
1.2.Macaca mulatta (rhesus monkey) 2. EHH19601
2 Bos taurus (domestic cow) AAI49917
3 Sus scrofa (wild pig) CAN13184
4 Heterocephalus glaber (naked mole rat) EHB02263
5 Tupaia chinensis (tree shrew) ELW71703
6 6.1.Pteropus alecto (black flying-fox) 6.1. ELK04290
6.2.Myotis brandtii (brandt’s bat) 6.2. EPQ07764
7 Bos grunniensmutus (wild yak) ELR53603
8 Rattus norvegicus (rat) P20417.1
9 Mus musculus (mouse) P35821.2
10 Gallus gallus (chicken) O13016
11 Chelonia mydas (green turtle) EMP35762
12 Anas platyrhynchos (wild duck) EOB08070
13 Xenopus (Silurana) tropicalis (tropical clawed frog) NP_001017121
14 Xenopus laevis (African clawed frog) NP_001086085
15 Danio rerio (zebrafish) CAQ14262
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unique peripheral site (Shen et al. 2001).
Because most of these inhibitors have a high number
of torsions, the docking scores estimated by AutoDock
Vina were calculated into the binding energies without
torsion interferences (Table 2). These computational
ΔGinter values were in relatively strong correlation
(Figure 6) with the observed binding energies calculated
from the experimental Ki values.
T. chinensis model had the strongest affinity to all six
inhibitors but showed differences with hPTP1B in bind-
ing modes of compound 1, 4 and 5. The binding site of
TuPTP1B did not have direct contact at residues Gln262
and Asp48 with compound 1 as the hPTP1B or mole-rat
PTP1B had (Figure 7). In the case of compound 4,
hydrophilic interaction of this ligand involved the resi-
dues Gln262, Gly259 and Ser28 in hPTP1B whereas it
happened around carboxylic group of the aromatic moi-
ety with tyrosine, glycine and aspartate residues in
TuPTP1B (Figure 8). Tupaia PTP1B also did not formTable 2 Calculated binding energies ΔGinter(kcal/mol) of six P
standard
H. sapiens S. scrofa T. chinensis H. glabe
Ertiprotafib −9.6 −9.6 −10.8 −9.6
Compound 1 −14.3 −13.5 −15.4 −14.6
Compound 2 −13.7 −14.8 −15.4 −14.2
Compound 3 −9.8 −9.8 −10.3 −9.8
Compound 4 −13.7 −13.9 −16.7 −14.2
Compound 5 −16.7 −14.1 −17 −13.9hydrogen bonds with compound 5 at residues Ser216
and Asp48 as in hPTP1B; instead it had indirect contact
with these residues (Figure 9).
Noticeably, the R.norvegicus (rat) and H.glaber (mole-
rat) models appeared to be best suited for inhibitor
studies of hPTP1B. Most of the inhibitors docked into
these models have close docking scores and rather simi-
lar binding modes with those in hPTP1B except for
compound 1 and compound 5 respectively (data not
shown). In this test, the M.musculus PTP1B was again
recognized to be less preferable than the rat particularly
with compound 4 and 5. While rPTP1B maintained the
direct contact with Gly259 to O8 of compound 4 and
most of other indirect contacts, mPTP1B revealed sig-
nificant difference as it solely had H-bonding to the lig-
and at Tyr46 in the active site (Figure 10). Especially,
mPTP1B has less affinity to compound 5 and a different
binding site for this molecule than hPTP1B whereas
rPTP1B showed the most similarity. There are at least
five H-bonds formed between Gln262, Ile219, Gly220,TP1B inhibitors to protein models with hPTP1B as
r M. brandtii P. alecto R. norvegicus M. musculus
−9.7 −9.7 −9.7 −9.6
−13.7 −13.7 −13.5 −13.7
−14.2 −13.7 −14.8 −13.9
−8.2 −9.7 −9.7 −9.5
−12.8 −13 −13.7 −12.3
−14.1 −15 −17.3 −14
Figure 6 The correlation between the computational interaction energies and the observed binding energies (ΔGobs) calculated from
the experimental Ki values of investigated inhibitors. ΔGobs = RT lnKi with ΔGobs: observed free energy change of binding; Ki: inhibition constant;
R: gas constant (1.987 cal K−1 mol−1); T: room temperature (298.15 K).
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binding pocket but mPTP1B could only preserve the
contact of Asp48 with the molecule (Figure 11).
P.alecto had strong affinity to compound 2, just as
hPTP1B does but it had weak affinity to compound 4
and 5. Most models had relatively good binding affinity
to compound 3, particularly the S.scrofa and H.glaber
models responsed the same as hPTP1B. However, in this
study, the hPTP1B binding site for compound 3 showed
slight differences to the experimental report (Iversen
et al. 2001). We could not observe the salt bridge be-
tween the molecule and Asp48 because, in our study,
there was no water molecule introduced during the con-
ventional docking procedure.Figure 7 Comparison in the binding site of hPTP1B (left) and of TuPT
pockets are visualizaed by LigPlot+ v.1.4. The ligands and protein side chain
coloured in pink. Hydrogen bonds are shown as green dotted lines with H
green with brown backbone whereas ones with indirect/hydrophobic interConclusions
This study intensively analyzes the phylogenetic relation-
ship between hPTP1B and other common vertebrates. Im-
portant mutations/variations in second-aryl binding sites,
adjacent regions of Q loop and hydrophobic core structure
should be noticeable as protein conformational differences
which are likely to lead to disagreement between in silico
design and in vivo testing. Rats, as a common model, are
more preferable for having higher similarity with hPTP1B
than mice while Heterocephalus glaber emerges as new
model due to better suitability and agreement in the target
PTP1B sequences.
Among all, H.glaber and R.norvegicus are preferred over
M.musculus thanks to their similarity in binding affinityP1B (right) to the peptidomimetic compound 1. The binding
s are shown in ball-and-stick representation, with the ligand bonds
-bond lengths. Residues with direct/hydrophilic contacts are colored in
actions are colored in black and indicated with the red spoked arcs.
Figure 8 Differences in binding sites of hPTP1B (left) and T.chinensis PTP1B (right) to compound 4. The analysis and illustration were
made by using LigPlot+ v.1.4.
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are also more common and available than other animals
as models for in vivo tests.
It is recommended that the study can be scaled up for
investigating more variety of potential PTP1B inhibitors
in these animal models. It is also necessary to study
whether functions of PTP1B homologs in these animals
are similar in human or not. In order to ensure the suc-
cess of drug development as well as to reduce time and
cost, the suitability of animal tests is very critical to pre-
vent false positive results.Figure 9 Comparison of the binding pocket of hPTP1B (left) and Tupa
made by using LigPlot+ v.1.4.Methods
Multiple sequence alignment and phylogenetic tree
construction
Full-length sequence of hPTP1B with 435 amino acids
(Swiss-Prot: P18031) collected from the UniProtKB
database (www.uniprot.org/) was the query sequence
for a Blastp (Altschul et al. 1990) search from the non-
redundant protein database with default parameters
(BLOSUM 62 matrix (Henikoff and Henikoff 1992)).
From a maximum 250 homologies, qualified sequences
which could represent the PTP1B homologs in differentia PTP1B (right) for compound 5. The analysis and illustration were
Figure 10 Similarity of binding pocket of rat PTP1B model to hPTP1B leading to superiority of rat model over the mouse model – specific
case with compound 4. The analysis and illustration were made by using LigPlot+ v.1.4.
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ment (MSA) using Clustal Omega (Sievers et al. 2011)
with input ordered and Phylip output format (www.ebi.ac.
uk/Tools/msa/clustalo/). The result of MSA was also
compared and verified by T-Coffee method (Notredame
et al. 2000) and the algorithm of genetic semihomology
(Leluk 1998; Leluk et al. 2001) respectively. The consensus
sequence of aligned PTP-non receptor type 1 sequences
was then constructed with the aid of Consensus con-
structor (Fogtman and Lesyng 2005). The parameters used
were: identity 91.67%, significance 29.17%, gaps 50%.
The refined MSA was then used as input for theFigure 11 Similarity of the binding pocket of rat PTP1B model to hPT
model – specific case with compound 5. The analysis and illustration weconstruction of a phylogenetic tree by the PHYML ap-
proach (Guindon and Gascuel 2003) which implements
the maximum likelihood method. The options were ad-
justed for amino acid data type, Jones, Taylor, and
Thornton (JTT) substitution model and tree topology
best searching of NNI (Nearest Neighbor Interchange)
and SPR (Subtree Prune and Regraft) search.Analysis of evolutionary conservativity
The evolutionary conservativity/variability of aligned pro-
tein homologies was calculated with the help of ConsurfP1B leading to superiority of rat model over the mouse
re made by using LigPlot+ v.1.4.
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2010) (http://consurf.tau.ac.il/). The conservativity scores
were calculated by Bayesian method. JTT was the evolu-
tionary substitution model applied. Evolutionarily func-
tional positions and regions were also analyzed on the
basis of the hPTP1B structure [PDB: 2VEV] and visualized
by Chimera (Meng et al. 2006) version 1.8 (www.cgl.ucsf.
edu/chimera/).Inhibitor docking into PTP1B models
The 3D structures of PTP1B of most potential animal
candidate were constructed by homology modeling on
the Swiss-Model server (http://swissmodel.expasy.org)
from the template hPTP1B catalytic domain structure
(residues 1–321) on Protein Data Bank (PDB: 2VEV).
The model quality was mainly evaluated based on the
QMEAN4 score which is a composite score consisting
of a linear combination of 4 statistical potential terms
(estimated model reliability between 0–1) and RMSD
values.
Six PTP1B inhibitors reviewed (Zhang and Lee 2003)
were prepared in 3D structures. The docking step between
newly modeled protein structures and these inhibitors was
undergone by AutoDock Vina package (Trott and Olson
2010). The ligands were prepared by the graphical user
interface AutoDockTools (http://mgltools.scripps.edu/
downloads). The input ligands were added Gasteiger
charged if missing, merged non-polar H, detected rotat-
able bonds and then set Torsion degree of freedom
(TORSDOF). The receptors were also prepared as pdbqt
file with the grid map information. The center of the
grid box was (17, 18, 77) and applied to all the recep-
tor structures as they are written in the same pattern
of coordinates. This box has the size of 30Ǻ at each
square face and cover both known binding pockets of
PTP1B. The docking step was run with two CPU, ex-
haustiveness 10 and only the binding mode with the
lowest free binding energy was recorded. The resulting
docking scores were the predicted free binding energies
(Gibbs, ΔG) with the intramolecular contributions taken
into account (c = cinter + cintra). The predicted docking
scores in this study were then re-calculated into the inter-
action energies that avoid the interferences caused by high
torsion numbers of the inhibitors (with more than 10 ro-
tatable bonds). The following formula helped compute the
final binding energies:
ΔGinter = ΔGpred *(1 + 0.05846 Nrot) (Trott and Olson
2010)
Binding modes were further analyzed in the context
with protein binding sites by LigPlot+ v.1.4 (Laskowski
and Swindells 2011).Additional file
Additional file 1: Quality of PTP1B models built by homology
modeling on Swiss-Model server (http://swissmodel.expasy.org)
with hPTP1B (pdb: 2vev) as template.
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